FBTAX
Price
$31.35
Change
-$0.25 (-0.79%)
Updated
Sep 25 closing price
Net Assets
1.46B
RYCFX
Price
$44.07
Change
-$0.84 (-1.87%)
Updated
Sep 25 closing price
Net Assets
89.1M
Interact to see
Advertisement

FBTAX vs RYCFX

Header iconFBTAX vs RYCFX Comparison
Open Charts FBTAX vs RYCFXBanner chart's image
Fidelity Advisor Biotechnology A
Price$31.35
Change-$0.25 (-0.79%)
VolumeN/A
Net Assets1.46B
Rydex Biotechnology C
Price$44.07
Change-$0.84 (-1.87%)
VolumeN/A
Net Assets89.1M
FBTAX vs RYCFX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
FBTAX vs. RYCFX commentary
Sep 26, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FBTAX is a Hold and RYCFX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
FBTAX has more cash in the bank: 1.46B vs. RYCFX (89.1M). FBTAX pays higher dividends than RYCFX: FBTAX (2.59) vs RYCFX (0.00). FBTAX was incepted earlier than RYCFX: FBTAX (25 years) vs RYCFX (25 years). RYCFX (2.43) is less costly to investors than FBTAX (0.96). RYCFX is a more actively managed with annual turnover of: 79.00 vs. FBTAX (73.00). FBTAX has a lower initial minimum investment than RYCFX: FBTAX (0) vs RYCFX (2500). FBTAX annual gain was more profitable for investors over the last year : -1.29 vs. RYCFX (-15.50). FBTAX return over 5 years is better than : 4.86 vs. RYCFX (-36.62).
FBTAXRYCFXFBTAX / RYCFX
Total Expense Ratio0.962.3840%
Annual Report Gross Expense Ratio0.962.4340%
Fund Existence25 years25 years-
Gain YTD16.13410.589152%
Front Load6%N/A-
Min. Initial Investment02500-
Min. Initial Investment IRAN/AN/A-
Net Assets1.46B89.1M1,641%
Annual Yield % from dividends2.590.00-
Returns for 1 year-1.29-15.508%
Returns for 3 years43.752.931,491%
Returns for 5 years4.86-36.62-13%
Returns for 10 years44.83-33.80-133%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SILLF0.210.01
+7.07%
Sarine Technologies Ltd.
HKMPF21.87N/A
N/A
Hikma Pharmaceuticals plc.
PMHS0.20N/A
N/A
Polomar Health Services, Inc.
PRYMF98.00N/A
N/A
Prysmian S.P.A.
SPPJY1.42-0.08
-5.33%
Sappi Ltd.